These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9818764)

  • 1. In-vitro activity of a combination of two oral beta-lactams (cefpodoxime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin.
    Johnson DM; Jones RN
    J Antimicrob Chemother; 1998 Oct; 42(4):555-7. PubMed ID: 9818764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
    Calvo A; Amores R; Valero E; Sevillano D; Prieto J;
    Rev Esp Quimioter; 2001 Dec; 14(4):345-50. PubMed ID: 11856980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae.
    Pérez-Trallero E; Alkorta M; García-Arenzana JM; Iturzaeta A; Gomariz M
    J Antimicrob Chemother; 1998 Jun; 41(6):629-34. PubMed ID: 9687101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.
    Butler DL; Gagnon RC; Miller LA; Poupard JA; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1999 Jun; 43(6):777-82. PubMed ID: 10404316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
    Fenoll A; Robledo O; Lerma M; Giménez MJ; Cebrián L; Casal J; Aguilar L; Gómez-Lus ML
    Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2786-9. PubMed ID: 9420061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae.
    Pérez-Trallero E; Marimón JM; Ercibengoa M; Giménez MJ; Coronel P; Aguilar L
    Clin Microbiol Infect; 2007 Sep; 13(9):937-40. PubMed ID: 17617182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
    Pérez-Trallero E; Alkorta M; Giménez MJ; Vicente D; Aguilar L
    J Chemother; 2001 Apr; 13(2):118-25. PubMed ID: 11330357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.
    Bingen E; Doit C; Loukil C; Brahimi N; Bidet P; Deforche D; Geslin P
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2345-7. PubMed ID: 12821495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in-vitro activities of co-amoxiclav and other oral antibiotics against Streptococcus pneumoniae isolates exhibiting intermediate susceptibility to penicillin.
    Washington JA; Felmingham D
    J Antimicrob Chemother; 1998 Sep; 42(3):405-6. PubMed ID: 9786488
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae.
    Cuffini AM; Tullio V; Ianni Palarchio A; Bonino A; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1998; 24(4):173-84. PubMed ID: 10051963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
    Goldstein FW
    Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri.
    Kays MB; Wood KK; Miles DO
    Pharmacotherapy; 1999 Nov; 19(11):1308-14. PubMed ID: 10555936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996].
    Geslin P; Fremaux A; Sissia G; Spicq C; Georges S
    Arch Pediatr; 1998 Sep; 5(9):982-7. PubMed ID: 9789629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994-96.
    Georgopoulos A; Buxbaum A; Straschil U; Graninger W
    Scand J Infect Dis; 1998; 30(4):345-9. PubMed ID: 9817512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.
    Appelbaum PC; Spangler SK; Crotty E; Jacobs MR
    J Antimicrob Chemother; 1989 Apr; 23(4):509-16. PubMed ID: 2545656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activities of amoxycillin and penicillin against Streptococcus pneumoniae isolates.
    Vanhoof R
    J Antimicrob Chemother; 1998 Sep; 42(3):397-8. PubMed ID: 9786482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.